A pharmacokinetic phase I study to assess the bioavailability and pharmacokinetics of Fentanyl from a metered dose transdermal system (MDTS) in pai

Phase 1

Completed

• Conditions: Pain; Other - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)

• Registration Number: ACTRN12605000524695
• Lead Sponsor: Acrux DDS Pty Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-26
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

Healthy volunteers

Exclusion Criteria

No exclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified